1. Idiopathic Intracranial Hypertension and Facial Palsy: Case Report and Review of the Literature
- Author
-
Antigone Siamopoulou-Mavridou, Vasilios Grammeniatis, Anastasia K. Zikou, Maria Argyropoulou, Iliada Nakou, Meropi Tzoufi, Alexandros Makis, Ioannis Asproudis, and Georgios Exarchakos
- Subjects
medicine.medical_specialty ,Pseudotumor Cerebri/*complications/drug therapy ,medicine ,Humans ,Initial treatment ,Elevated Intracranial Pressure ,Cerebral venous sinus thrombosis ,Child ,Abducens nerve ,Pseudotumor Cerebri ,Palsy ,business.industry ,medicine.disease ,Surgery ,Venous thrombosis ,Treatment Outcome ,Pediatrics, Perinatology and Child Health ,Prednisolone ,Facial Nerve Diseases/drug therapy/*etiology ,Female ,Neurology (clinical) ,Facial Nerve Diseases ,business ,Acetazolamide ,medicine.drug - Abstract
We present the case of an 11-year-old obese girl who presented with idiopathic intracranial hypertension affecting first the lateral abducens nerve. She received acetazolamide, but 5 days later she developed lateral, peripheral facial palsy. Imaging evaluation was normal, which primarily excluded cerebral venous thrombosis and sustained the initial diagnosis. Despite some complicating factors (obesity, elevated intracranial pressure), prednisolone was administered for a short-term period to counteract the facial palsy. Ophthalmological residuals resolved within almost 1.5 months, while facial palsy receded after 4 months. Peripheral facial palsy is an extremely rare, but not unknown condition in idiopathic intracranial hypertension. As a symptom, it should be investigated thoroughly, primarily to exclude cerebral venous sinus thrombosis, before it can be attributed to idiopathic intracranial hypertension. As far as treatment is concerned, corticosteroids can be added to the initial treatment with acetazolamide, without worsening already elevated intracranial hypertension or ophthalmologic findings.
- Published
- 2010
- Full Text
- View/download PDF